Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
Pavlo Petakh(Kyiv School of Economics), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Nazarii Kobyliak(Bogomolets National Medical University)
Cited by 37
Related Papers
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
|Biomedicines|2024|51
Current treatment options for leptospirosis: a mini-review
|Frontiers in Microbiology|2024|48